France-based private equity house Keensight Capital has acquired a majority stake in 3P Biopharmaceuticals, a Spain-based contract development and manufacturing organisation (CDMO), from parent company Infarco.
Georg Parlasca will remain in charge of operations and strategy as managing director
Apollo increases its stake after initially buying 48.67% of Gamenet from Trilantic in October 2019
Apax Partners acquired a stake in Idealista from Bonsai Venture Capital et al. in July 2015
HIG is currently investing from Growth Buyout Equity Fund III, which closed on $970m